# Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity

Study · id `cardio:ct-nct01915459` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01915459](<https://clinicaltrials.gov/study/NCT01915459>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01915459

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 186 participants.

## Technical summary

Registry record NCT01915459. Randomized; double masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 186 participants (enrolled count; ClinicalTrials.gov record NCT01915459, source copy `cardio:ctgov-nct01915459-2015-05-04`, retrieved 2026-10-26)
- Start date: 2013-06 (registry gives no type) (ClinicalTrials.gov record NCT01915459, source copy `cardio:ctgov-nct01915459-2015-05-04`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01915459, source copy `cardio:ctgov-nct01915459-2015-05-04`, retrieved 2026-10-26)
- Completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01915459, source copy `cardio:ctgov-nct01915459-2015-05-04`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01915459, source copy `cardio:ctgov-nct01915459-2015-05-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01915459-2015-05-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity
- Condition: Stroke
- Condition: Spasticity
- Intervention (Biological): Botulinum toxin type A(Botulax®)
- Intervention (Biological): Botulinum toxin type A(Botox®)
- Lead sponsor: Hugel
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 3558bebfba5a59518b4faa1ef62e45c40208ae97d1a5cdb77645e0411c606dbe
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
